Pulse Biosciences, Inc. (PLSE) Tops Q4 EPS by 2c

Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q4 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.

You May Also Be Interested In

• Software catches a bid as investors rotate ahead of Palantir earnings
• Sportradar Group AG (SRAD) Misses Q2 EPS by 6c, Offers Guidance
• Hess Midstream Partners LP (HESM) Tops Q2 EPS by 6c